German generics and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) today released financial results, which the ...

(Bloomberg) -- German drugmaker Stada Arzneimittel AG could break open the market for European initial public offerings again as it gears up for what could be the region’s largest listing this year.

German pharmaceutical company Stada Arzneimittel has opened a new production facility in Turda, Romania. Initially announced ...

Private equity firm Hellman & Friedman is interviewing banks for a listing of Verisure that could value the security group at ...

Only $2.5 billion has been raised through European initial public offerings so far this year, according to data compiled by ...

Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...

Issuers will hope the outperformance continues, as consensus is now that there will be no EPS growth in Q1. Bank of America ...